EcoDrugPlus

Aldo-Keto Reductase Family 1 Member B1-Like

Ensembl ID : ENSGMOG00000006697
Gene Symbol: LOC115531901
2 Cross references
343 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSGMOG00000036288
Gene Symbol: LOC115547498
2 Cross references
195 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSGMOG00000029402
Gene Symbol: LOC115532510
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSGMOG00000003109
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSGMOG00000016739
Gene Symbol: AOC2
2 Cross references
406 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSGMOG00000003156
Gene Symbol: APP
3 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSGMOG00000010216
Gene Symbol: AR
1 Cross references
213 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSGMOG00000004074
Gene Symbol: LOC115552233
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSGMOG00000026261
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSGMOG00000023538
Gene Symbol: APLNR2
2 Cross references
171 Possible Orthologues:

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSGMOG00000032733
Gene Symbol: LOC115537362
2 Cross references
168 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSGMOG00000006677
Gene Symbol: ALOX5A
3 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).